Literature DB >> 2311860

Comparison of endogenous and radiolabeled bile acid excretion in patients with idiopathic chronic diarrhea.

L R Schiller1, L E Bilhartz, C A Santa Ana, J S Fordtran.   

Abstract

Fecal recovery of radioactivity after ingestion of a bolus of radiolabeled bile acid is abnormally high in most patients with idiopathic chronic diarrhea. To evaluate the significance of this malabsorption, concurrent fecal excretion of both exogenous radiolabeled bile acid and endogenous (unlabeled) bile acid were measured in patients with idiopathic chronic diarrhea. Subjects received a 2.5-microCi oral dose of taurocholic acid labeled with 14C in the 24th position of the steroid moiety. Endogenous bile acid excretion was measured by a hydroxysteroid dehydrogenase assay on a concurrent 72-h stool collection. Both radiolabeled and endogenous bile acid excretion were abnormally high in most patients with chronic diarrhea compared with normal subjects, even when equivoluminous diarrhea was induced in normal subjects by ingestion of osmotically active solutions. The correlation between radiolabeled and endogenous bile acid excretion was good. However, neither radiolabeled nor endogenous bile acid excretion was as abnormal as is typically seen in patients with ileal resection, and none of these diarrhea patients responded to treatment with cholestyramine with stool weights less than 200 g. These results suggest (a) that this radiolabeled bile acid excretion test accurately reflects excess endogenous bile acid excretion; (b) that excess endogenous bile acid excretion is not caused by diarrhea per se; (c) that spontaneously occurring idiopathic chronic diarrhea is often associated with increased endogenous bile acid excretion; and (d) that bile acid malabsorption is not likely to be the primary cause of diarrhea in most of these patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311860     DOI: 10.1016/0016-5085(90)90031-u

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Fillers can transform people's lives.

Authors:  J Le Fanu
Journal:  BMJ       Date:  2001-04-21

2.  Guidelines for the investigation of chronic diarrhoea, 2nd edition.

Authors:  P D Thomas; A Forbes; J Green; P Howdle; R Long; R Playford; M Sheridan; R Stevens; R Valori; J Walters; G M Addison; P Hill; G Brydon
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

3.  Disorder of bile acid metabolism in children with short bowel syndrome.

Authors:  N Ohkohchi; T Andoh; U Izumi; Y Igarashi; R Ohi
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

4.  Role of bile acids and bile acid binding agents in patients with collagenous colitis.

Authors:  K A Ung; R Gillberg; A Kilander; H Abrahamsson
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

Review 5.  Microscopic colitis syndrome--a review article.

Authors:  Jesse A Otegbayo; Folasade M Otegbeye; Olorunda Rotimi
Journal:  J Natl Med Assoc       Date:  2005-05       Impact factor: 1.798

Review 6.  Bile salt diarrhea.

Authors:  Bruce W Robb; Jeffrey B Matthews
Journal:  Curr Gastroenterol Rep       Date:  2005-10

7.  Bile Acid malabsorption.

Authors:  Henrik Westergaard
Journal:  Curr Treat Options Gastroenterol       Date:  2007-02

8.  Serum 7 alpha-hydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: correlation to SeHCAT test.

Authors:  S Eusufzai; M Axelson; B Angelin; K Einarsson
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.